Onto Innovation Inc 8-K, filed Jun 16, 2025
Onto Innovation Inc. (ONTO)
About this 8-K
Onto Innovation Inc filed this 8-K on June 16, 2025, reporting on events of June 11, 2025.
Items reported
- Item 5.02: Director or officer change, or executive pay
- Item 9.01: Financial statements and exhibits
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934
Date of Report (Date of earliest event reported): |
(Exact name of Registrant as Specified in Its Charter)
(State or Other Jurisdiction |
(Commission File Number) |
(IRS Employer |
||
|
|
|
|
|
|
||||
|
||||
(Address of Principal Executive Offices) |
|
(Zip Code) |
||
Registrant’s Telephone Number, Including Area Code: |
|
(Former Name or Former Address, if Changed Since Last Report)
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
Securities registered pursuant to Section 12(b) of the Act:
|
|
Trading |
|
|
|
|
Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§ 230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§ 240.12b-2 of this chapter).
Emerging growth company
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐
Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.
(c) On June 12, 2025, Onto Innovation Inc. (the “Company”) announced that Brian Roberts has been appointed as the Company’s Chief Financial Officer (“CFO”) effective as of June 16, 2025 (the “Hire Date”). Mr. Roberts will serve as the Company’s principal financial officer and principal accounting officer.
Mr. Roberts, 54 years of age, most recently served as Chief Financial Officer of Sensata Technologies Holdings PLC, a global industrial technology company, from October 2023 to May 2025. Previously, he served from 2020 to 2022 as the Chief Executive Officer of Tarveda Therapeutics, a private venture backed oncology company, which he joined initially in the role of Chief Financial Officer from 2018 to 2020. He has approximately fifteen years of extensive public company experience including as CFO at Insulet Corporation, a high-growth medical technology business, from 2009 to 2014, and in various leadership roles including as CFO at Digitas, Inc., a marketing and technology services business, from 2001 to its acquisition in 2007. Mr. Roberts also has significant public company Board experience including serving as Chair of the Audit Committee and Board member for ViewRay, Inc. from 2015 to 2023. He also held leadership roles in several other companies including as Chief Operating and Financial Officer of Averdo, Inc., a pharmaceutical and medical device company, as VP Finance at Idiom Technologies, a provider of globalization software, and as U.S. Controller of Monitor Company, a strategic consulting firm. Mr. Roberts started his career at Ernst & Young LLP and is a Certified Public Accountant. He holds a Bachelor of Science in Accounting Finance from Boston College.
In connection with his appointment as the Company’s CFO, the Company and Mr. Roberts entered into an employment agreement, effective as of the Hire Date (the “Employment Agreement”). The material terms and conditions of the Employment Agreement are summarized below.
Mr. Roberts will receive (a) an annualized base salary of $525,000; (b) a cash bonus target incentive of 80% of his base salary (or a higher percentage as determined by the Chief Executive Officer and approved by the Company’s Board of Directors (the “Board”) or a committee of the Board) and for the fiscal year ending January 3, 2026, eligibility for a full year cash bonus without proration from the Hire Date; (c) a one-time equity grant of time-based restricted stock units with a value of $2,200,000 at the time of grant (vesting ratably over a three year period on the anniversary date of the grant); (d) a one-time cash signing bonus of $250,000, with a clawback provision requiring (i) 100% pay back if Mr. Roberts leaves within twelve (12) months following the Hire Date or (ii) 50% pay back if Mr. Roberts leaves between twelve (12) and twenty-four (24) months following the Hire Date; and (e) subject to the approval of the Compensation Committee of the Board and in accordance with the provisions of the Company’s 2020 Stock Plan and any applicable award agreement(s), eligibility to receive an annual equity grant in 2026 with 50% of the grant in the form of time-based restricted stock units and 50% of the grant in the form of performance-based restricted stock units. He is also eligible to participate under the Company’s other benefits plans, programs and perquisites.
The initial term of the Employment Agreement continues through September 2, 2026, subject to automatic renewals for additional one-year terms ending on September 2nd of the applicable year unless written notice of non-extension is provided by Mr. Roberts or by the Company at least ninety (90) days prior to the end of the then-current term. If Mr. Roberts’ employment is terminated, other than in connection with a “Change in Control Event,” by the Company without “Cause” or by Mr. Roberts for “Good Reason” (each foregoing capitalized term, as defined in the Employment Agreement), or under certain other circumstances as specified in the Employment Agreement, then Mr. Roberts is entitled to (i) a severance payment equal to one (1) time his annual base salary payable over twelve (12) months in accordance with the Company’s standard payroll practices for senior executives, (ii) a pro-rated bonus award for the year of termination based on actual achievement for the full year in which his employment was terminated, payable when the annual incentive compensation payments are made to other senior executives under the Company’s Annual Cash Incentive Plan, and (iii) accelerated vesting of Mr. Roberts’ Roberts’ stock options and stock appreciation rights granted after the Hire Date that would have vested during the twelve (12) month period following the termination, and continued exercisability of such awards until the first to occur of the second (2nd) anniversary of the termination date and the original expiration date of the award.
If Mr. Roberts’ employment is terminated (a) by the Company without Cause or (b) by Mr. Roberts for Good Reason upon or within eighteen (18) months following a Change in Control Event, then Mr. Roberts is entitled to (i) a severance payment equal to one (1) time his annual base salary, payable over twelve (12) months in accordance with the Company’s standard payroll practices for senior executives, (ii) one (1) time his target bonus award, also payable over twelve (12) months in accordance with the Company’s standard payroll practices for senior executives, (iii) accelerated vesting of Mr. Roberts’ stock options and stock appreciation rights granted after the Hire Date that would have vested during the twelve (12) month period following the termination, and continued exercisability of such awards until the first to occur of the second (2nd) anniversary of the termination date and the original expiration date of the award, (iv) accelerated vesting, and payment within forty-five (45) days following termination, of all other then-outstanding equity awards, with performance-based awards vesting at target, and (v) a pro-rated bonus award for the year of termination based on actual achievement for the full year in which his employment was terminated, payable when the annual incentive compensation payments are made to other senior executives under the Company’s Annual Cash Incentive Plan.
If Mr. Roberts’ employment is terminated at any time (whether or not in connection with a Change in Control Event) by the Company without Cause or by Mr. Roberts for Good Reason, Mr. Roberts will be entitled to COBRA benefits for up to twelve (12)
months following the termination date. The Employment Agreement also provides for benefits in connection with termination of employment due to death or disability.
Mr. Roberts is subject to a non-competition covenant during his employment term and for twelve (12) months thereafter, unless Mr. Roberts breaches his fiduciary duties to the Company or takes confidential or proprietary Company information, in which case the post-employment non-competition period will be twenty-four (24) months. Mr. Roberts is also subject to a non-solicitation covenant during his employment term and for twelve (12) months thereafter.
The foregoing description of Mr. Roberts’ Employment Agreement is qualified in its entirety by reference to the full text of the Employment Agreement, which is included as Exhibit 10.1 to this Current Report on Form 8-K and is incorporated herein by reference.
There is no arrangement or understanding between Mr. Roberts and any other person pursuant to which Mr. Roberts was appointed as CFO. There are no family relationships between Mr. Roberts and any of the Company’s directors, executive officers or persons nominated or chosen by the Company to become a director or executive officer. Mr. Roberts has not engaged in any related-person transactions required to be disclosed by Item 404(a) of Regulation S-K under the Securities Exchange Act of 1934, as amended.
Item 9.01 Financial Statements and Exhibits.
(d) Exhibits
Exhibit No. |
|
Description of Exhibit |
|
|
|
|
Employment Agreement between Onto Innovation Inc. and Brian Roberts, effective as of June 16, 2025 |
|
104 |
|
Cover Page Interactive Data File (embedded within the Inline XBRL document) |
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
|
|
|
Onto Innovation Inc. |
|
|
|
|
Date: |
June 16, 2025 |
By: |
/s/ Yoon Ah Oh |
|
|
|
Yoon Ah Oh |
EXHIBIT 10.1
EMPLOYMENT AGREEMENT
This Employment Agreement (“Agreement”) is entered into by and between Onto Innovation, Inc., a Delaware corporation (“Company”) and Brian Roberts (“Executive”) and is effective on June 16, 2025 (“Effective Date”).
WHEREAS, the Company wishes to employ Executive as its Chief Financial Officer (“CFO”) beginning on the Effective Date; and
WHEREAS, Executive desires to commence employment with the Company as its CFO on the Effective Date.
NOW, THEREFORE, in consideration of the Company’s continued employment of Executive and the mutual covenants and agreements set forth herein, the Company and Executive hereby enter into this Agreement.
1
2
Executive shall be eligible for his first Equity Grant in the Company’s Fiscal Year 2026. Once granted and any applicable agreements are completed, the Executive’s Restricted Share Unit Award will be governed by the terms of the Onto Innovation 2020 Stock Plan, the Grant, and any applicable award agreement, and not the terms of this Employment Agreement.
3
4
To be treated as resigning for Good Reason, Executive must provide written notice to the Company effective within sixty (60) days after the first occurrence of such event, notifying the Company of the “Good Reason;” provide the Company with at least thirty (30) days to correct the purported Good Reason; and actually resign effective within sixty (60) days after the earlier of the date the Company provides written notice that it will not correct the Good Reason or the end of the cure period.
5
6
Except as provided in this Section 6(a), Section 6(h) below shall apply to all equity incentive awards (of any type or nature including time-based awards) granted on or after the Effective Date and which are outstanding as of the Termination Date.
7
8
For purposes of this definition, persons will be considered to be acting as a group if they are owners of a corporation that enters into a merger, consolidation, purchase or acquisition of stock, or similar business transaction with Company.
In addition, to the extent required for compliance with Section 409A, in no event will a Change in Control be deemed to have occurred if such transaction is not also a “change in the ownership or effective control of” the Company or a “change in the ownership of a substantial portion of the assets of” the Company, as determined under Treasury Regulations Section 1.409A-3(i)(5).
9
10
11
To the extent not vested pursuant to clause (A), (B) or (C) above, all New Equity Awards of Executive outstanding at the time of the termination of employment due to death or Disability under this Section 7 shall terminate as of the Termination Date due to death or Disability, except only as may otherwise be provided in any applicable Company equity incentive award agreement granted to Executive.
For purposes of this Agreement, “Competitive Business” with the Company means (1) any activity which involves the sale, distribution, design and/or manufacturing of precision film thickness measurement instruments, defect and yield metrology tools, advanced packaging lithography equipment or data analysis systems for use in the semiconductor manufacturing industry; and (2) any other business in which the Company is engaged during the Employment Term or proposed to engage under plans being developed during the Employment Term, in each case, under clause (1) or (2) above, within any geographical area in which the Company engages in business. Executive acknowledges and agrees that, in his role as CFO, he will have a material presence or influence in any geographical area in which the Company engages in business.
The Company may elect to enforce the provisions of this Section 8(a) or waive them at its sole discretion. If the Company elects to waive the provisions of this Section 8(a), the Company will provide Executive written notice of such waiver on or before the last day of Executive’s employment with the Company pursuant to an involuntary termination, or within one (1) week after the Company’s receipt of written notice from Executive of Executive’s resignation. If the Company does not elect to waive the provisions of this Section 8(a), and the Executive is not entitled to
12
Compensation following Termination of Employment under Section 6 of this Agreement, then, in lieu of garden leave, Company and Executive have mutually agreed that a one-time payment of $231,750 (“mutually-agreed consideration”) will be made on the next regular payroll date following termination of his employment and is subject to all applicable withholdings. Executive acknowledges and agrees that the mutually agreed upon consideration includes consideration for Executive’s agreement to the obligations in this Section 8 and, in addition to the other rights and entitlements set forth in this Agreement, constitutes fair and reasonable consideration for such obligations.
For avoidance of doubt, the Company’s failure to timely waive the provisions of this Section 8(a) shall be construed as its election to enforce the provisions of this Section. For avoidance of any further doubt, if the Company elects to waive the provisions of this Section 8(a), or the Company is otherwise prohibited by law or a court from enforcing the provisions of this Section, Executive will not be subject to the restrictions in this Section nor will he be entitled to the Mutually-agreed Consideration.
13
14
15
16
17
To The Company:
16 Jonspin Road
Wilmington, MA 01887
Attention: Chief Executive Officer
With copy to:
Office of General Counsel
16 Jonspin Road
Wilmington, MA 01887
To Executive: at the last address shown on the records of the Company maintained by the Company’s Human Resources Department with a copy to:
Cravath, Swaine & Moore LLP
Two Manhattan West
375 Ninth Avenue
18
New York, NY 10001
Attention: Minh Van Ngo
E-mail: mngo@cravath.com
19
[Signature page follows]
20
IN WITNESS WHEREOF, the parties hereto have executed this Agreement as of the Effective Date set forth above.
EXECUTIVE: THE COMPANY:
___/s/ Brian Roberts ___________ By: ___/s/ Mike Plisinski_______
Brian Roberts Name: Mike Plisinski
Title: Chief Executive Officer
21